1-7 of 7
Sebastian Schneeweiss
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes

Available to Purchase
Phyo Than Htoo, Mehdi NajafZadeh, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Robert J. Glynn, Niklas Schmedt, Anouk Déruaz-Luyet, Lisette Koeneman, Julie M. Paik, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2024;47(11):1900–1907
https://doi.org/10.2337/dc24-0270
Published: 25 June 2024
View articletitled, Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes
Open the PDF for Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes in another window
Journal Articles

Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes

Free
Alexander Kutz, Dae Hyun Kim, Deborah J. Wexler, Jun Liu, Sebastian Schneeweiss, Robert J. Glynn, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2023;46(11):2004–2014
https://doi.org/10.2337/dc23-0671
Published: 07 September 2023
View articletitled, Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes
Open the PDF for Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes in another window
Journal Articles

Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study

Free
Devin Abrahami, Helen Tesfaye, Hui Yin, Seanna Vine, Blánaid Hicks, Oriana H.Y. Yu, Lysanne Campeau, Robert W. Platt, Sebastian Schneeweiss, Elisabetta Patorno, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2022;45(12):2907–2917
https://doi.org/10.2337/dc22-1174
Published: 28 September 2022
View articletitled, Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study
Open the PDF for Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study in another window
Journal Articles

Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA

Free
HoJin Shin, Sebastian Schneeweiss, Robert J. Glynn, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2021;44(8):1774–1782
https://doi.org/10.2337/dc20-2926
Published: 18 June 2021
View articletitled, Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA
Open the PDF for Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA in another window
Journal Articles

Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults

Free
Elisabetta Patorno, Ajinkya Pawar, Lily G. Bessette, Dae H. Kim, Chintan Dave, Robert J. Glynn, Medha N. Munshi, Sebastian Schneeweiss, Deborah J. Wexler, Seoyoung C. Kim
Journal: Diabetes Care
Diabetes Care 2021;44(3):826–835
https://doi.org/10.2337/dc20-1464
Published: 11 February 2021
View articletitled, Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults
Open the PDF for Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults in another window
Journal Articles

Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018

Free
Chintan V. Dave, Sebastian Schneeweiss, Deborah J. Wexler, Gregory Brill, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2020;43(4):921–924
https://doi.org/10.2337/dc19-1943
Published: 10 February 2020
View articletitled, Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018
Open the PDF for Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018 in another window
Includes: Supplementary data
Journal Articles

Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride

Free
Elisabetta Patorno, Sebastian Schneeweiss, Chandrasekar Gopalakrishnan, David Martin, Jessica M. Franklin
Journal: Diabetes Care
Diabetes Care 2019;42(12):2204–2210
https://doi.org/10.2337/dc19-0069
Published: 11 July 2019
View articletitled, Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride
Open the PDF for Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride in another window
Includes: Supplementary data